Efficacy of rocatinlimab for moderate-to-severe atopic dermatitis – Authors' reply

Emma Guttman-Yassky, Eric L. Simpson, Kristian Reich, Kenji Kabashima, Ken Igawa, Tetsuya Suzuki, Hirotaka Mano, Takeshi Matsui, Ehsanollah Esfandiari, Masutaka Furue

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1834
Number of pages1
JournalThe Lancet
Issue number10415
StatePublished - 18 Nov 2023

Cite this